All Stories

  1. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes

    Article • Artificial Cells Nanomedicine and Biotechnology, November 2018, Taylor & Francis

    Mr Armin Mooranian, Dr Frank Arfuso, Dr Hani Al-Salami

  2. Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses

    Article • Artificial Cells Nanomedicine and Biotechnology, September 2018, Taylor & Francis

    Mr Armin Mooranian, Dr Frank Arfuso, Dr Hani Al-Salami, Prof. Goran Stojanovic

  3. The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic β-cells: biomaterials, osmotic forces and potential applications in diabetes treatment

    Article • Pharmaceutical Development and Technology, May 2017, Taylor & Francis

    Mr Armin Mooranian, Dr Hani Al-Salami

  4. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

    Article • Drug Design Development and Therapy, September 2014, Taylor & Francis

    Dr Hani Al-Salami, Mr Armin Mooranian, Dr Frank Arfuso, Professor Svetlana Stevan Golocorbin-Kon, Professor Momir Mikov

  5. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer

    Article • Drug Design Development and Therapy, September 2014, Taylor & Francis

    Dr Hani Al-Salami, Mr Armin Mooranian, Dr Frank Arfuso

  6. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study

    Article • Drug Design Development and Therapy, July 2014, Taylor & Francis

    Dr Hani Al-Salami, Mr Armin Mooranian, Dr Frank Arfuso, Professor Svetlana Stevan Golocorbin-Kon, Professor Momir Mikov, Dr Zhongxiang Fang

  7. Inflammatory bowel disease: clinical aspects and treatments

    Article • Journal of Inflammation Research, June 2014, Taylor & Francis

    Dr Hani Al-Salami, Mr Armin Mooranian